Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
FEBS Lett. 2000 Jul 28;478(1-2):183-6.

Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains.

Author information

  • 1Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, DD1 9SY, Dundee, UK.


The MDM2 oncoprotein is a negative regulatory partner of the p53 tumour suppressor. MDM2 mediates ubiquitination of p53 and targets the protein to the cytoplasm for 26S proteosome-dependent degradation. In this paper, we show that MDM2 is modified in cultured cells by multisite phosphorylation. Deletion analysis of MDM2 indicated that the sites of modification fall into two clusters which map respectively within the N-terminal region encompassing the p53 binding domain and nuclear export sequence, and the central acidic domain that mediates p14(ARF) binding, p53 ubiquitination and cytoplasmic shuttling. The data are consistent with potential regulation of MDM2 function by multisite phosphorylation.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk